Virtus Fund Advisers, LLC Haemonetics Corp Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 1,358 shares of HAE stock, worth $105,747. This represents 0.45% of its overall portfolio holdings.
Number of Shares
1,358
Previous 1,306
3.98%
Holding current value
$105,747
Previous $111,000
0.9%
% of portfolio
0.45%
Previous 0.4%
Shares
4 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$538 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$464 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$400 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$299 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$299 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...